recombinant herpes zoster vaccine
Phase 3- Indications
- Herpes zoster
Company intelligence / Profile preview
Shanghai Maikekang Biotechnology
Shanghai, Shanghai, Chinaaykbio.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
The herpes zoster vaccine uses a proprietary MA105 adjuvant system and recombinant protein technology, demonstrating good safety and tolerability in Phase I, and is in Phase II to further assess immunity and safety. The rotavirus vaccine is progressing through industrial scale-up and early development; both represent the first wave of a broader innovation pipeline.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Recombinant proteinAdjuvant systemVaccine
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Government and local industrial zone partnerships (e.g., Lingang Group, Life Blue Bay Fund)Government support at district and municipal level
Beyond the preview
Go deeper on Shanghai Maikekang Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Maikekang Biotechnology.